Salbutamol Inhaler Use in Preschool‑Age Children (≥4 years)

Device Selection and Technique

An MDI combined with a large‑volume spacer is the recommended delivery system for a 4‑year‑old child because most children this age cannot reliably coordinate an unmodified MDI. [1][2]3
Large‑volume spacer devices deliver medication more efficiently than nebulizers, which are frequently overused in both hospital and community settings. [1][2]3
Correct spacer technique: actuate the MDI, inhale the first puff, re‑actuate, inhale the second puff, and continue until the prescribed number of puffs has been taken. [1][2]4

Initiate therapy with 2 puffs (total ≈ 200 µg) of salbutamol as needed for symptom relief; doses may be repeated every 4–6 hours if cough persists or worsens. [1][2]
For children aged 3–4 years the recommended dose represents the maximal dose; many patients will achieve control with a smaller amount. [1][2]4
Relief doses may be administered every 2–4 hours outside the hospital, but lack of response or early clinical deterioration mandates immediate medical assessment. [1][2]3

The absence of wheeze on examination does not rule out asthma; recurrent cough—especially nocturnal cough—is a recognized asthma manifestation in this age group. 1
A history of prior wheeze and previous inhaler use further supports an underlying asthma diagnosis. [1][5]
Before escalating therapy, verify proper inhaler technique, confirm the asthma diagnosis, and ensure the family understands when and how to use the medication. [1][2]4
If frequent salbutamol use is required, prompt reassessment is essential because it signals poor control and the need for controller therapy. 1

When as‑needed salbutamol fails to provide adequate control, restart or initiate controller therapy (e.g., inhaled corticosteroids) rather than increasing bronchodilator frequency. [1][5]3
Inhaled corticosteroids constitute the cornerstone of preventive treatment for children with persistent asthma symptoms. [1][5][3][4]
Successful management is defined by minimal daytime symptoms, no nocturnal awakenings, and infrequent need for rescue medication. [1][5]2

Provide both oral and written instructions covering correct inhaler use, signs that require urgent medical help, and strategies for avoiding environmental triggers. [1][2]4
Educate caregivers on the distinction between “relievers” (bronchodilators) and “preventers” (anti‑inflammatory agents). [5][3]
Emphasize the importance of avoiding cigarette‑smoke exposure and other known asthma triggers. [1][2][4][6]

Routine use of nebulizers should be avoided; they are more costly, time‑consuming, and less efficient than an MDI with a spacer. [1][2][7][3]
Do not prescribe an unmodified MDI without a spacer to a 4‑year‑old child. [1][2][3][4]
Delay in reassessing a child who requires frequent salbutamol indicates suboptimal control and should prompt initiation of controller therapy. 1